C9301 – Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Long description

Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Short description

Obecabtagene car pos t

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Cross reference

Q2058

Added

April 1, 2025

Last change

July 1, 2025 – No change

Termination date

June 30, 2025

Nearby C codes

• C9250 – Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
• C9254 – Injection, lacosamide, 1 mg
• C9257 – Injection, bevacizumab, 0.25 mg
• C9275 – Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
• C9285 – Lidocaine 70 mg/tetracaine 70 mg, per patch
• C9290 – Injection, bupivacaine liposome, 1 mg
• C9293 – Injection, glucarpidase, 10 units
• C9300 – Injection, indigotindisulfonate sodium, 1 mg
• C9302 – Injection, zanidatamab-hrii, 2 mg
• C9303 – Injection, zolbetuximab-clzb, 1 mg
• C9304 – Injection, marstacimab-hncq, 0.5 mg
• C9305 – Injection, nipocalimab-aahu, 3 mg
• C9306 – Injection, telisotuzumab vedotin-tllv, 1 mg
• C9307 – Injection, linvoseltamab-gcpt, 1 mg
• C9308 – Injection, carboplatin (avyxa), 1 mg
• C9309 – Injection, onasemnogene abeparvovec-brve, per treatment